Didier Meseure
Overview
Explore the profile of Didier Meseure including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1538
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, et al.
Cancer Res
. 2022 Jul;
82(18):3291-3306.
PMID: 35862581
Significance: This work identifies a novel lipid-associated macrophage subpopulation with immune suppressive functions, offering new leads for therapeutic interventions in triple-negative breast cancer.
12.
Ramos R, Missolo-Koussou Y, Gerber-Ferder Y, Bromley C, Bugatti M, Gonzalo Nunez N, et al.
Cell
. 2022 Mar;
185(7):1189-1207.e25.
PMID: 35325594
Macrophage infiltration is a hallmark of solid cancers, and overall macrophage infiltration correlates with lower patient survival and resistance to therapy. Tumor-associated macrophages, however, are phenotypically and functionally heterogeneous. Specific...
13.
Nguyen Ho-Bouldoires T, Sollier K, Zamfirov L, Broders-Bondon F, Mitrossilis D, Bermeo S, et al.
Commun Biol
. 2022 Feb;
5(1):137.
PMID: 35177769
How mechanical stress actively impacts the physiology and pathophysiology of cells and tissues is little investigated in vivo. The colon is constantly submitted to multi-frequency spontaneous pulsatile mechanical waves, which...
14.
Suresh S, Huard S, Brisson A, Nemati F, Dakroub R, Poulard C, et al.
Cancers (Basel)
. 2022 Jan;
14(2).
PMID: 35053470
Identifying new therapeutic strategies for triple-negative breast cancer (TNBC) patients is a priority as these patients are highly prone to relapse after chemotherapy. Here, we found that protein arginine methyltransferase...
15.
Santana Dos Santos E, Spurdle A, Carraro D, Briaux A, Southey M, Torrezan G, et al.
NPJ Breast Cancer
. 2022 Jan;
8(1):9.
PMID: 35039532
At least 10% of the BRCA1/2 tests identify variants of uncertain significance (VUS) while the distinction between pathogenic variants (PV) and benign variants (BV) remains particularly challenging. As a typical...
16.
Verrelle P, Meseure D, Berger F, Forest A, Leclere R, Nicolas A, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439087
Effective biomarkers predictive of the response to treatments are key for precision medicine. This study identifies the staining pattern of the centromeric histone 3 variant, CENP-A, as a predictive biomarker...
17.
Barret J, Nicolas A, Jarry A, Dubreuil O, Meseure D, Passat T, et al.
Biology (Basel)
. 2021 Apr;
10(4).
PMID: 33917111
The anti-Müllerian hormone (AMH) belongs to the TGF-β family and plays a key role during fetal sexual development. Various reports have described the expression of AMH type II receptor (AMHRII)...
18.
Csanyi-Bastien M, Lanic M, Beaussire L, Ferric S, Francois A, Meseure D, et al.
Am J Surg Pathol
. 2021 Apr;
45(11):1487-1498.
PMID: 33899788
Secretory carcinoma (SC) is characterized by ETV6 rearrangements, most often ETV6-NTRK3 fusion. Given its histologic overlap with other salivary gland tumors (SGTs), SCs can be difficult to diagnose without genetic...
19.
Montaudon E, El Botty R, Vacher S, Deas O, Naguez A, Chateau-Joubert S, et al.
Oncotarget
. 2021 Apr;
12(8):859-872.
PMID: 33889306
Significant rational is available for specific targeting of PI3K/AKT/mTOR pathway in the treatment of non-small cell lung cancer (NSCLC). However, almost all clinical trials that have evaluated Pi3K pathway-based monotherapies/combinations...
20.
Neuzillet C, Marchais M, Vacher S, Hilmi M, Schnitzler A, Meseure D, et al.
Sci Rep
. 2021 Apr;
11(1):7870.
PMID: 33846399
Changes in the oral microbiome, particularly Fusobacterium nucleatum, are associated with oral squamous cell carcinoma (OSCC). F. nucleatum has been reported to modulate local immunity in cancers. We aimed to...